
Virpax Pharmaceuticals
Prolonged Analgesia From Bupisome And Bupigel Formulations: From Design And Fabrication To Improved Stability
Jan. 29, 2023
Courtesy ofVirpax Pharmaceuticals
Based on data from early animal studies, Probudur has indicated post-operative control for up to 96 hours, which is 24 hours longer than the leading product on the market. If we are able to demonstrate a successful Phase III clinical trial, we believe Probudur may represent the first long acting local anesthetic with an opioid sparing label.
Stay in the loop!
Select your areas of interest to receive industry updates.